NCT04714086 2024-10-24Expanded Access Program for AvapritinibBlueprint Medicines CorporationNo longer available
NCT03134131 2022-03-14Expanded Access to ONC201 for Patients With H3 K27M-mutant and/or Midline High Grade GliomasJazz PharmaceuticalsNo longer available1 FDA
NCT03460782 2019-11-08An Expanded Access Program of Ipilimumab for Patients With Glioblastomas and GliomasCenter Trials & TreatmentNo longer available
NCT03311542 2018-01-10Expanded Access for Pembrolizumab (MK-3475)Center Trials & TreatmentNo longer available